|Articles|August 11, 2015

Mark Lazenby on Measuring Distress in a Patient

Mark Lazenby, PhD, APRN, FAPOS, associate professor, Yale School of Nursing, discusses tools to measure distress in a patient with cancer.

Knowledge is power. Don’t miss the most recent breakthroughs in cancer care.

Related to this article

November 7th, 2026

In a 117-patient cohort, 35% waited over 60 days for neoadjuvant chemotherapy, most often because of added workup, second opinions or comorbidities.

November 6th, 2026

Interviews with 15 young women with breast cancer show fertility preservation decisions unfold under time pressure and carry into survivorship.

November 6th, 2026

Lisa Carter-Bawa, PhD, MPH, APRN, explains how nurses can counter lung cancer fatalism by pairing honesty with hope and using teach-back.

November 3rd, 2026

Interim AYA-NAV data show most navigation components reached young patients with cancer as designed, though full sessions lagged during treatment.

November 1st, 2026

As bispecifics and cell therapies move outpatient, Kate Kennedy, MSN, APRN, says nurses and APPs should focus on education and atypical infections.

October 30th, 2026

A 3-minute video and quick-reference list of October's 7 FDA cancer approvals, with the biomarker and monitoring points nurses need for each.

October 30th, 2026

Oral vitamin C did not slow clonal growth in the phase 2 EVITA trial but was linked to longer survival.

October 29th, 2026

Kathryn Shady, PhD, RN, OCN, discusses research on emotional dissonance and vicarious trauma among hematology/oncology nurses.